Value £553,000,000

Neko Health

VC Funding

Series C £500m+ Angel-backed

Healthcare & Biotech Published 25 September 2026

Summary

HealthTech pioneer Neko Health has completed a $700 million Series C funding round to support its international expansion into the United States.

Summary of transaction details:

Value: $700 million
Sector: Healthcare & Biotech
Advisor: Not disclosed
Key Entities: Neko Health, Daniel Ek, Hjalmar Nilsonne
Location: New York, USA

Note: The capital injection enables Neko Health to bring its innovative non-invasive health scanning technology to the US market, targeting high rates of chronic disease through early detection and preventive care.

Lead Investor / Acquirer

Undisclosed Investors

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Series C prioritised

VC Funding

Scan.com

£67,220,000

Sept 2026

VC Funding

Stream

£67,000,000

Jan 2024

VC Funding

Babylon Health

£24,490,661

May 2020

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

View Company Details

Financials, officers, full deal history

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.